Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ahmad R. Alsayed, Abdullah Al-Dulaimi, Mohammad Alkhatib, Mohammed Al Maqbali, Mohammad A. A Al-Najjar & Mamoon M.D. Al-Rshaidat. (2022) A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients. Expert Review of Respiratory Medicine 16:11-12, pages 1167-1190.
Read now
Read now
Neil T. Hoa, Lisheng Ge, Filippo Martini, Vincent Chau, Amrita Ahluwalia, Carol A. Kruse & Martin R. Jadus. (2016) Temozolomide induces the expression of the glioma Big Potassium (gBK) ion channel, while inhibiting fascin-1 expression: possible targets for glioma therapy. Expert Opinion on Therapeutic Targets 20:10, pages 1155-1167.
Read now
Read now
Ella J Ariza-Heredia & Roy F Chemaly. (2015) Practical review of immunizations in adult patients with cancer. Human Vaccines & Immunotherapeutics 11:11, pages 2606-2614.
Read now
Read now
Sophia Koo, Deanna A. Sutton, Wendy W. Yeh, Elizabeth H. Thompson, Lynne Sigler, Judy F. Shearer, Deborah E. Hofstra, Brian L. Wickes & Francisco M. Marty. (2012) Invasive Mycoleptodiscus fungal cellulitis and myositis. Medical Mycology 50:7, pages 740-745.
Read now
Read now
David A Reardon, James R Perry, Alba A Brandes, Rakesh Jalali & Wolfgang Wick. (2011) Advances in malignant glioma drug discovery. Expert Opinion on Drug Discovery 6:7, pages 739-753.
Read now
Read now
Raffaele Addeo & Michele Caraglia. (2011) Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?. Expert Opinion on Investigational Drugs 20:7, pages 881-895.
Read now
Read now
Articles from other publishers (44)
L. Hänsel, J. Schumacher, B. Denis, S. Hamane, O.A. Cornely & P. Koehler. (2023) How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?. Clinical Microbiology and Infection 29:8, pages 1015-1023.
Crossref
Crossref
Seth A. Climans, Warren P. Mason, Eva Grunfeld & Kelvin Chan. (2022) Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy. Journal of Neuro-Oncology 159:3, pages 665-674.
Crossref
Crossref
Roberto Mapelli, Chiara Julita, Sofia Paola Bianchi, Nicolò Gallina, Raffaella Lucchini, Martina Midulla, Flavia Puci, Jessica Saddi, Sara Trivellato, Denis Panizza, Elena De Ponti & Stefano Arcangeli. (2021) Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy. Strahlentherapie und Onkologie 198:5, pages 448-457.
Crossref
Crossref
Taymeyah Al-ToubahEleonora PelleTiffany ValoneMintallah HaiderJonathan R. Strosberg. (2022) Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms. Journal of the National Comprehensive Cancer Network 20:1, pages 29-36.
Crossref
Crossref
R. Ursu, J. Doridam, E. Chaugne, H. Zannou, C. Belin, S. Cuzzubbo, L. Sirven-Villaros, S. Brichler, C. Levy-Piedbois & A. F. Carpentier. (2021) Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy. Journal of NeuroVirology 27:1, pages 94-100.
Crossref
Crossref
Clément Brault, Yoann Zerbib, Taieb Chouaki, Julien Maizel & Rémy Nyga. (2021) Temozolomide is a risk factor for invasive pulmonary aspergillosis: A case report and literature review. Infectious Diseases Now.
Crossref
Crossref
Anna Pozza, Bruno Pauletti, Marco Scarpa, Cesare Ruffolo, Nicolò Bassi & Marco Massani. (2019) Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery. International Journal of Colorectal Disease 34:11, pages 1849-1856.
Crossref
Crossref
Shiyuan Anabeth Liu, Timothy Sullivan, Clare Bryce, Amy M Chan & Salvatore Cilmi. (2019) Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme. BMJ Case Reports 12:5, pages e227500.
Crossref
Crossref
Ryutaro Furukawa, Hirokuni Homma, Tomohiro Inoue, Hajime Horiuchi & Kazuhiro Usui. (2018) Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide. Internal Medicine 57:20, pages 3047-3050.
Crossref
Crossref
David A. Reardon, Patrick Y. Wen, Kai W. Wucherpfennig & John H. Sampson. (2017) Immunomodulation for glioblastoma. Current Opinion in Neurology 30:3, pages 361-369.
Crossref
Crossref
K. Ina Ly & Patrick Y. Wen. (2017) Clinical Relevance of Steroid Use in Neuro-Oncology. Current Neurology and Neuroscience Reports 17:1.
Crossref
Crossref
Daniela Mueller, Sebastian Krug, Moushumee Majumder, Anja Rinke & Thomas Matthias Gress. (2016) Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors. BMC Cancer 16:1.
Crossref
Crossref
Luis Gorospe Saras?a, Almudena Ure?a-Vacas & Jacobo Rodrigo Mu?oz del Toro. (2016) Neumon?a por Pneumocystis jirovecii complicando la evoluci?n de una paciente con glioblastoma multiforme en tratamiento con temozolomida. Archivos de Bronconeumolog?a 52:10, pages 534-535.
Crossref
Crossref
Luis Gorospe Saras?a, Almudena Ure?a-Vacas & Jacobo Rodrigo Mu?oz del Toro. (2016) Pneumocystis jirovecii Pneumonia Complicating the Progress of a Patient with Glioblastoma Multiforme Receiving Temozolomide. Archivos de Bronconeumolog?a (English Edition) 52:10, pages 534-535.
Crossref
Crossref
G. Mellon, B. Henry, O. Aoun, D. Boutolleau, A. Laparra, J. Mayaux, M. Sanson & E. Caumes. (2016) Adenovirus related lymphohistiocytic hemophagocytosis: Case report and literature review. Journal of Clinical Virology 78, pages 53-56.
Crossref
Crossref
Takeshi Saraya, Naoki Tsujimoto, Yoshifumi Yamada, Hiroki Nunokawa, Kosuke Ohkuma, Shota Yonetani, Hiroshi Makino, Koji Araki, Yayoi Tsukahara, Masachika Fujiwara, Haruyuki Ishii & Hajime Takizawa. (2016) Hidden Disease with Pulmonary Alveolar Hemorrhage. Journal of General and Family Medicine 17:1, pages 77-82.
Crossref
Crossref
Adrienne G. Waks, Sara M. Tolaney, Alicia Galar, Amal Arnaout, Julie B. Porter, Francisco M. Marty, Eric P. Winer, Sarah P. Hammond & Lindsey R. Baden. (2015) Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors. Breast Cancer Research and Treatment 154:2, pages 359-367.
Crossref
Crossref
Brett J. Loechelt, Michael Green, Peter A. Gottlieb, Emily Blumberg, Adriana Weinberg, Scott Quinlan & Lindsey R. Baden. (2015) Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders. Journal of the Pediatric Infectious Diseases Society 4:3, pages 198-204.
Crossref
Crossref
Omar Abdel-Rahman & Mona Fouad. (2015) Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature. Future Oncology 11:8, pages 1275-1290.
Crossref
Crossref
Shengnan Fu, Yanqi Xie, Jue Tuo, Yalong Wang, Wenbo Zhu, Sihan Wu, Guangmei Yan & Haiyan Hu. (2015) Discovery of mitochondria-targeting berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells. MedChemComm 6:1, pages 164-173.
Crossref
Crossref
Ahmed I. Megahed & Henry B. Koon. (2014) What Is the Role of Chemotherapy in the Treatment of Melanoma?. Current Treatment Options in Oncology 15:2, pages 321-335.
Crossref
Crossref
Alyssa R. Letourneau, Nicolas C. Issa & Lindsey R. Baden. (2014) Pneumonia in the immunocompromised host. Current Opinion in Pulmonary Medicine 20:3, pages 272-279.
Crossref
Crossref
M. P. Christman, S. E. Turbett, S. Sengupta, K. U. Bakhadirov, C. A. Williamson, L. Nayak, T. Milligan & J. T. Katz. (2014) Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma: a case report and review of the literature. Oxford Medical Case Reports 2014:1, pages 1-4.
Crossref
Crossref
Jenny P. Tsai, Nicolae Petrescu, Warren P. Mason & Leanne K. Casaubon. (2014) Concomitant Viral and Bacterial Encephalitis after Temozolomide for Glioblastoma. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 41:1, pages 84-85.
Crossref
Crossref
Mona Gandhi, Joaquin C. Brieva & Mario E. Lacouture. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients
299
317
.
Yevgeniy Balagula, Mario E. Lacouture & James I. Ito. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology
319
336
.
Masaki Okada, Keisuke Miyake, Aya Shinomiya, Nobuyuki Kawai & Takashi Tamiya. (2013) Relapse of herpes encephalitis induced by temozolomide-based chemoradiation in a patient with malignant glioma. Journal of Neurosurgery 118:2, pages 258-263.
Crossref
Crossref
Matthew H. Kulke. (2013) Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors. Seminars in Oncology 40:1, pages 75-83.
Crossref
Crossref
Sanjay Dixit, Louise Baker, Vicki Walmsley & Mohan Hingorani. (2012) Temozolomide-related idiosyncratic and other uncommon toxicities. Anti-Cancer Drugs 23:10, pages 1099-1106.
Crossref
Crossref
Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, Makoto Ohno, Kohki Aihara, Shinichiro Mori, Takamasa Kayama & Soichiro Shibui. (2011) Reactivation of cytomegalovirus following treatment of malignant glioma with temozolomide. International Cancer Conference Journal 1:1, pages 53-57.
Crossref
Crossref
Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, Makoto Ohno, Shoichi Nagai & Soichiro Shibui. (2012) Management of Cytomegalovirus Infection in a Patient with Malignant Glioma Treated with Temozolomide and Steroids. Internal Medicine 51:20, pages 2967-2971.
Crossref
Crossref
Duane A. Mitchell, Xiuyu Cui, Robert J. Schmittling, Luis Sanchez-Perez, David J. Snyder, Kendra L. Congdon, Gary E. Archer, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, James E. HerndonIIII, Roger E. McLendon, David A. Reardon, James J. Vredenburgh, Darell D. Bigner & John H. Sampson. (2011) Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. Blood 118:11, pages 3003-3012.
Crossref
Crossref
T. Jaeger, C. Andres, J. Ring & M.D. Anliker. (2011) Rhodotorula mucilaginosa infection in Li-Fraumeni-like syndrome: a new pathogen in folliculitis. British Journal of Dermatology 164:5, pages 1120-1122.
Crossref
Crossref
Makoto OHNO, Yoshitaka NARITA, Yasuji MIYAKITA, Hideki UENO, Takamasa KAYAMA & Soichiro SHIBUI. (2011) Reactivation of Hepatitis B Virus After Glioblastoma Treatment With Temozolomide. Neurologia medico-chirurgica 51:10, pages 728-731.
Crossref
Crossref
Mini Kamboj & David M. Weinstock. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
359
370
.
Sandrine Faivre, Marie-Paule Sablin, Chantal Dreyer & Eric Raymond. (2010) Novel Anticancer Agents in Clinical Trials for Well-Differentiated Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 39:4, pages 811-826.
Crossref
Crossref
Jann N. Sarkaria, Eva Galanis, Wenting Wu, Allan B. Dietz, Timothy J. Kaufmann, Michael P. Gustafson, Paul D. Brown, Joon H. Uhm, Ravi D. Rao, Laurence Doyle, Caterina Giannini, Kurt A. Jaeckle & Jan C. Buckner. (2010) Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks. Clinical Cancer Research 16:22, pages 5573-5580.
Crossref
Crossref
Konstantinos Gousias & Athanasios Kyritsis. (2010) Comment on “Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma”. Journal of Clinical Neuroscience 17:3, pages 412.
Crossref
Crossref
Eiichi ISHIKAWA, Tetsuya YAMAMOTO, Noriaki SAKAMOTO, Kei NAKAI, Hiroyoshi AKUTSU, Koji TSUBOI, Shingo TAKANO & Akira MATSUMURA. (2010) Low Peripheral Lymphocyte Count Before Focal Radiotherapy Plus Concomitant Temozolomide Predicts Severe Lymphopenia During Malignant Glioma Treatment. Neurologia medico-chirurgica 50:8, pages 638-644.
Crossref
Crossref
Ana De Jesus, Stuart A. Grossman & Oana Paun. (2009) Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. Journal of Neuro-Oncology 94:3, pages 445-448.
Crossref
Crossref
Emel Yaman, Ugur Coskun, Banu Ozturk, Suleyman Buyukberber, Ali Osman Kaya, Ozlem Coskun, Nuray Buyukberber, Ramazan Yildiz & Mustafa Benekli. (2009) Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. Journal of Clinical Neuroscience 16:4, pages 591-592.
Crossref
Crossref
Tadeu Ferreira de PaivaJr.Jr., Milton José de Barros e Silva, José Augusto RinckJr.Jr., Marcello Ferreti Fanelli & Daniel Luiz Gimenes. (2008) Tuberculosis in a patient on temozolomide: a case report. Journal of Neuro-Oncology 92:1.
Crossref
Crossref
Van Anh Trinh. (2008) Current management of metastatic melanoma. American Journal of Health-System Pharmacy 65:24_Supplement_9, pages S3-S9.
Crossref
Crossref
L.. Guilleminault, P.. Carré, K.. de Luca, F.. Beau Salinas, E.. Autret-Leca, B.. Narciso & P.. Diot. (2008) Pneumonie alvéolo-interstitielle au témozolomide. Revue des Maladies Respiratoires 25:7, pages 880-884.
Crossref
Crossref